63 related articles for article (PubMed ID: 8648108)
21. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
Milisauskas VK; Nakamura I
J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
[TBL] [Abstract][Full Text] [Related]
22. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.
Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P
J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098
[TBL] [Abstract][Full Text] [Related]
23. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
[TBL] [Abstract][Full Text] [Related]
24. Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.
Manilay JO; Waneck GL; Sykes M
J Immunol; 1999 Sep; 163(5):2628-33. PubMed ID: 10453002
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cell recognition of "self" and "non-self" triggering antigens on normal lymphoblasts.
Hirayama M; Genyea C; Kaplan J
Cell Immunol; 1996 Oct; 173(1):33-48. PubMed ID: 8871599
[TBL] [Abstract][Full Text] [Related]
26. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
[TBL] [Abstract][Full Text] [Related]
27. Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells.
Carlow DA; Payne U; Hozumi N; Roder JC; Czitrom AA
Eur J Immunol; 1990 Apr; 20(4):841-6. PubMed ID: 2347364
[TBL] [Abstract][Full Text] [Related]
28. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
Mason LH
J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
[TBL] [Abstract][Full Text] [Related]
29. Differential effects on T cell and NK cell development by tissue-specific expression of H-2D(d) transgene.
Johansson MH; Bieberich C; Kâse-Sjöström A; Yoshioka T; Höglund E; Christy BA; Scangos G; Kärre K; Jay G; Höglund P
Eur J Immunol; 2000 Feb; 30(2):525-33. PubMed ID: 10671208
[TBL] [Abstract][Full Text] [Related]
30. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
[TBL] [Abstract][Full Text] [Related]
32. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells.
Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG
J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670
[TBL] [Abstract][Full Text] [Related]
33. Evidence for sulfate modification of H-2Dd on N-linked carbohydrate(s): possible involvement in Ly-49A interaction.
Chang CS; Kane KP
J Immunol; 1998 May; 160(9):4367-74. PubMed ID: 9574541
[TBL] [Abstract][Full Text] [Related]
34. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.
Kubota A; Kubota S; Farrell HE; Davis-Poynter N; Takei F
Cell Immunol; 1999 Feb; 191(2):145-51. PubMed ID: 9973537
[TBL] [Abstract][Full Text] [Related]
36. A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.
Carlson GA; Taylor BA; Marshall ST; Greenberg AH
Immunogenetics; 1984; 20(3):287-300. PubMed ID: 6469290
[TBL] [Abstract][Full Text] [Related]
37. Two-dimensional gel comparisons of murine H-2D region-associated antigens of different H-2 haplotypes.
Nichols EA; Krakauer T; Hansen TH
J Immunol; 1983 Nov; 131(5):2440-4. PubMed ID: 6631011
[TBL] [Abstract][Full Text] [Related]
38. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor.
Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF
J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020
[TBL] [Abstract][Full Text] [Related]
39. One (H-2D2b) of the three Db region-controlled molecules (H-2D1b, H-2D2b, H-2Lb) is not detected in bm13 mutant.
Iványi D; Démant P
J Immunol; 1983 Sep; 131(3):1080-4. PubMed ID: 6604086
[TBL] [Abstract][Full Text] [Related]
40. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
Ostrand-Rosenberg S; Cohan VL
J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
